|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
|
|---|---|---|---|
| Revenue, net | |||
| Cost of revenue, net | |||
| Gross profit | |||
| Operating expenses: | |||
| Research and development | |||
| Sales and marketing | |||
| General and administrative | |||
| Total operating expenses | |||
| Income (loss) from operations | |||
| Non-operating income(expense): | |||
| Investment Income | |||
| Interest expenses, net | |||
| Total other expense | |||
| Interest expense, net | |||
| Total other expense | |||
| Loss before income tax expense | |||
| Income tax benefit/(expense) | |||
| Consolidated net loss | |||
| Less: Net loss Attributable to Non-Controlling Interest | |||
| Net loss | |||
| Net loss attributable to common stockholders | |||
| Basic net loss per share of common stock (in Dollars per share) | |||
| Diluted net loss per share of common stock (in Dollars per share) | |||
| Weighted average shares used to compute basic net loss per share (in Shares) | |||
| Weighted average shares used to compute diluted net loss per share (in Shares) |
Loading...